465 related articles for article (PubMed ID: 34592890)
1.
Chen T; Ding R; Chen X; Lu Y; Shi J; Lü Y; Tang B; Zhang W; Ye C; Yuan M; Yang Z
Bioengineered; 2021 Dec; 12(1):8233-8246. PubMed ID: 34592890
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota May Play a Significant Role in the Pathogenesis of Graves' Disease.
Jiang W; Yu X; Kosik RO; Song Y; Qiao T; Tong J; Liu S; Fan S; Luo Q; Chai L; Lv Z; Li D
Thyroid; 2021 May; 31(5):810-820. PubMed ID: 33234057
[No Abstract] [Full Text] [Related]
4. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
5. Characterization and comparison of the bacterial microbiota in different gastrointestinal tract compartments of Mongolian horses.
Su S; Zhao Y; Liu Z; Liu G; Du M; Wu J; Bai D; Li B; Bou G; Zhang X; Dugarjaviin M
Microbiologyopen; 2020 Jun; 9(6):1085-1101. PubMed ID: 32153142
[TBL] [Abstract][Full Text] [Related]
6. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
[TBL] [Abstract][Full Text] [Related]
7. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
8. A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.
Piñero F; Vazquez M; Baré P; Rohr C; Mendizabal M; Sciara M; Alonso C; Fay F; Silva M
Ann Hepatol; 2019; 18(3):480-487. PubMed ID: 31023615
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiome Dysbiosis in Patients with Endometrial Cancer vs. Healthy Controls Based on 16S rRNA Gene Sequencing.
Li Y; Liu G; Gong R; Xi Y
Curr Microbiol; 2023 Jun; 80(8):239. PubMed ID: 37294364
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome cannot mask the changes of faecal microbiota compositions caused by primary hepatocellular carcinoma.
Ni J; Fu C; Huang R; Li Z; Li S; Cao P; Zhong K; Ge M; Gao Y
Lett Appl Microbiol; 2021 Jul; 73(1):73-80. PubMed ID: 33768575
[TBL] [Abstract][Full Text] [Related]
11. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.
Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Kudryavtseva A; Krasnov G
World J Gastroenterol; 2022 Mar; 28(10):1067-1077. PubMed ID: 35431497
[TBL] [Abstract][Full Text] [Related]
12. Profiling of tumour-associated microbiota in human hepatocellular carcinoma.
Komiyama S; Yamada T; Takemura N; Kokudo N; Hase K; Kawamura YI
Sci Rep; 2021 May; 11(1):10589. PubMed ID: 34012007
[TBL] [Abstract][Full Text] [Related]
13. Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma.
Zhang W; Xu X; Cai L; Cai X
Sci Rep; 2023 May; 13(1):7797. PubMed ID: 37179446
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
15. Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma.
Iida N; Mizukoshi E; Yamashita T; Terashima T; Arai K; Seishima J; Kaneko S
Int J Cancer; 2019 Nov; 145(10):2701-2711. PubMed ID: 30980680
[TBL] [Abstract][Full Text] [Related]
16. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
[TBL] [Abstract][Full Text] [Related]
17. Metagenomic analysis of gut microbiota in non-treated plaque psoriasis patients stratified by disease severity: development of a new Psoriasis-Microbiome Index.
Dei-Cas I; Giliberto F; Luce L; Dopazo H; Penas-Steinhardt A
Sci Rep; 2020 Jul; 10(1):12754. PubMed ID: 32728075
[TBL] [Abstract][Full Text] [Related]
18. Features of the gut microbiota in ulcerative colitis patients with depression: A pilot study.
Chen DL; Dai YC; Zheng L; Chen YL; Zhang YL; Tang ZP
Medicine (Baltimore); 2021 Feb; 100(7):e24845. PubMed ID: 33607855
[TBL] [Abstract][Full Text] [Related]
19. Sex-dependent associations between addiction-related behaviors and the microbiome in outbred rats.
Peterson VL; Richards JB; Meyer PJ; Cabrera-Rubio R; Tripi JA; King CP; Polesskaya O; Baud A; Chitre AS; Bastiaanssen TFS; Woods LS; Crispie F; Dinan TG; Cotter PD; Palmer AA; Cryan JF
EBioMedicine; 2020 May; 55():102769. PubMed ID: 32403084
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the fecal microbiota of infants with botulism.
Shirey TB; Dykes JK; Lúquez C; Maslanka SE; Raphael BH
Microbiome; 2015 Nov; 3():54. PubMed ID: 26593441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
